The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
The marketing of a disease: female sexual dysfunction
Open accessAbstract
In the shadows of this overmedicalisation, the pharmaceutical industry is meeting unexpected resistance to its attempts to sell women the next big profitable “disease,” female sexual dysfunction. This condition is claimed by enthusiastic proponents to affect 43% of American women,4 yet widespread and growing scientific disagreement exists over both its definition and prevalence. In addition, the meaningful benefits of experimental drugs for women's sexual difficulties are questionable, and the financial conflicts of interest of experts who endorse the notion of a highly prevalent medical condition are extensive. These controversies have been brought into focus by the rejection of Proctor and Gamble's experimental testosterone patch by advisers to the US Food and Drug Administration in December 2004.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Sexual Dysfunction in the United States: Prevalence and Predictors
Laumann, E. O., Paik, A., & Rosen, R. C. (1999) · JAMA · doi:10.1001/jama.281.6.537 · Cited by 5,119
BASSON, R., BERMAN, J., BURNETT, A., DEROGATIS, L., FERGUSON, D., FOURCROY, J., GOLDSTEIN, I., GRAZIOTTIN, A., HEIMAN, J., LAAN, E., et al. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67828-7 · Cited by 1,257
Moynihan, R., G⊘tzsche, P. C., Heath, I., & Henry, D. (2002) · BMJ · doi:10.1136/bmj.324.7342.886 · Cited by 900
Self-citationDistress about sex: a national survey of women in heterosexual relationships.
Bancroft, J., Loftus, J., & Long, J. S. (2003) · Archives of Sexual Behavior · doi:10.1023/a:1023420431760 · Cited by 774
Revised Definitions of Women's Sexual Dysfunction
Basson, R., Leiblum, S., Brotto, L., Derogatis, L., Fourcroy, J., Fugl-Meyer, K., Graziottin, A., Heiman, J. R., Laan, E., Meston, C., et al. (2004) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2004.10107.x · Cited by 455
The making of a disease: female sexual dysfunction
Moynihan, R. (2003) · BMJ · doi:10.1136/bmj.326.7379.45 · Cited by 325
Self-citationPark, K., Goldstein, I., Andry, C., Siroky, M., Krane, R., & Azadzoi, K. (1997) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900258 · Cited by 237
Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options
Berman, J. R., Berman, L., & Goldstein, I. (1999) · Urology · doi:10.1016/s0090-4295(99)00230-7 · Cited by 224
Berman, J. R., & Goldstein, I. (2001) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70148-8 · Cited by 187
Cited by
Nicolosi, A., Laumann, E. O., Glasser, D. B., Moreira, E. D., Paik, A., & Gingell, C. (2004) · Urology · doi:10.1016/j.urology.2004.06.055 · Cited by 591
Leiblum, S. R., Koochaki, P. E., Rodenberg, C. A., Barton, I. P., & Rosen, R. C. (2006) · Menopause · doi:10.1097/01.gme.0000172596.76272.06 · Cited by 444
Nazareth, I., Boynton, P., & King, M. (2003) · BMJ · doi:10.1136/bmj.327.7412.423 · Cited by 226
What is a disease?: Disease, disability and their definitions
Scully, J. L. (2004) · The EMBO Reports · doi:10.1038/sj.embor.7400195 · Cited by 195
Sex in Australia: sexual difficulties in a representative sample of adults
Richters, J., Grulich, A. E., de Visser, R. O., Smith, A. M. A., & Rissel, C. E. (2003) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.2003.tb00804.x · Cited by 183
Metadata
- Authors
- Moynihan, R.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2005-01-20
- Volume
- 330
- Issue
- 7484
- Pages
- 192-194
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W1979417661
- Cited by
- 321
- References
- 16
- FWCI
- 19.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The marketing of a disease: female sexual dysfunction. https://app.cochat.ai/papers/10.1136/bmj.330.7484.192
- The paper
- Moynihan, R. (2005). The marketing of a disease: female sexual dysfunction. BMJ. https://doi.org/10.1136/bmj.330.7484.192
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
